Summit Therapeutics (SMMT) EBITDA Margin (QoQ) (2017 - 2022)
Summit Therapeutics (SMMT) EBITDA Margin (QoQ) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -229,915.00 |
| Jun 30, 2022 | 346,235.00 |
| Mar 31, 2022 | 151,409.00 |
| Dec 31, 2021 | -888,867.00 |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | -3.28 Mn |
| Mar 31, 2021 | -256,758.00 |
| Dec 31, 2020 | 311,318.00 |
| Sep 30, 2020 | -32,673.00 |
| Jun 30, 2020 | -262,322.00 |
| Mar 31, 2020 | -642,391.00 |
| Dec 31, 2019 | 419,662.00 |
| Oct 31, 2019 | -239,529.00 |
| Oct 31, 2018 | -331,052.00 |
| Jul 31, 2018 | 55,128.00 |
| Apr 30, 2018 | 25,535.00 |
| Jan 31, 2018 | -23,026.00 |
| Oct 31, 2017 | -27,145.00 |
| Jul 31, 2017 | 48,148.00 |